Category: Inflammatory bowel disease

Over the past decade, several branded mesalamine products like Asacol and Asacol HD have been voluntarily discontinued by their manufacturers for commercial and regulatory reasons. While this is a significant development, it does not mean the entire medication class is being discontinued, but rather reflects strategic business decisions, leaving many patients wondering why is mesalamine being discontinued.

Nearly 3 million adults in the United States have been diagnosed with Inflammatory Bowel Disease (IBD), and finding an effective treatment strategy is crucial. For those managing conditions like Ulcerative Colitis or Crohn's Disease, figuring out which medications can be combined safely is a common question. For example, 'Can you take mesalamine and budesonide together?', is a question with a clear answer: under a doctor's supervision, yes, as these two medications can be used in combination to manage flare-ups and maintain remission.

Did you know that taking certain common medications, such as ibuprofen, can significantly increase your risk of kidney damage when combined with Pentasa? Understanding what not to take with Pentasa is critical for patients with inflammatory bowel disease to avoid potentially serious adverse effects from drug interactions.

Buscopan is a widely used antispasmodic medication, but confusion often arises about its purpose, especially regarding whether **does Buscopan help an inflamed bowel** directly. This antispasmodic is designed to relieve cramps by relaxing the smooth muscles of the digestive tract, not to treat the underlying inflammation that characterizes conditions like Inflammatory Bowel Disease (IBD).

Approximately 50% of patients with mild-to-moderate inflammatory bowel disease (IBD) will fail first-line mesalamine therapy, necessitating a conversation with their healthcare provider about what is the next step after mesalamine. This progression involves moving to more potent medications or adding adjunctive therapies, depending on disease severity and type.

Fatigue is one of the most common and debilitating symptoms of inflammatory bowel disease (IBD), affecting up to 80% of patients with active disease. Given this, many people ask: **Can mesalamine cause extreme fatigue?** While fatigue can be a less common side effect of mesalamine, it's crucial to understand the multiple potential causes to find the right path to management.

While uncommon, some reports have linked mesalamine to severe hematologic complications, including aplastic anemia and thrombocytopenia, which can lead to unexplained bleeding and bruising. For this reason, anyone asking, 'Can mesalamine cause bruising?' needs to understand the signs and severity of this rare adverse effect. It is a symptom that should be addressed immediately by a healthcare provider.

The cost of brand-name medications can vary significantly, and for a 120-capsule supply of Dipentum (olsalazine), the average retail price can exceed $2,100 before discounts. For patients managing ulcerative colitis, understanding how much does Dipentum cost is crucial for budgeting and finding affordable treatment options.

Inflammatory bowel disease affects an estimated 1.6 million people in the United States, and for those with mild to moderate cases, the anti-inflammatory medication mesalamine is a common treatment. The primary purpose of this medication is to reduce swelling and irritation in the lining of the intestines. This comprehensive guide explores **what is the drug mesalamine used for**, detailing its applications, mechanism, and different forms.

Over 2 million Americans suffer from inflammatory bowel disease (IBD), and a common question among patients is, "Can you take sulfasalazine and mesalamine together?" While both are in the same drug class, co-administration is generally avoided by healthcare professionals due to an increased risk of side effects without a clear therapeutic benefit.